Perrigo (PRGO) Cash from Operations (2013 - 2026)
Perrigo (PRGO) posted quarterly Cash from Operations of 113600000.0 for Q1 2026, down 76.12% year-over-year from 475792207.79 in Q1 2025, and down 164.77% quarter-over-quarter from 175400000.0 in Q4 2025.
Perrigo (PRGO) Cash from Operations (2013 - 2026) Analysis & Trends
Perrigo (PRGO) has reported Cash from Operations for 14 consecutive years, with 113600000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Cash from Operations fell 76.12% year-over-year to 113600000.0; the TTM figure through Mar 2026 stood at 189400000.0 (down 36.82% YoY), while the FY2025 annual figure was 238500000.0, down 34.28% from the prior year.
- Cash from Operations eased to 113600000.0 in Q1 2026 per PRGO's latest filing, from 175400000.0 in the prior quarter.
- Across five years, Cash from Operations topped out at 312600000.0 in Q4 2024 and bottomed at 113600000.0 in Q1 2026.
- Historically, Cash from Operations has averaged 70623529.41 across 5 years, with a median of 52900000.0 in 2023.
- Annual changes were most pronounced in 2022 — Cash from Operations surged 39450.0% — and 2025, when it tumbled 4507.14%.
- Perrigo's Cash from Operations stood at 185900000.0 in 2022, then climbed by 12.26% to 208700000.0 in 2023, then soared by 49.78% to 312600000.0 in 2024, then tumbled by 43.89% to 175400000.0 in 2025, then tumbled by 164.77% to 113600000.0 in 2026.
- Business Quant data shows PRGO's Cash from Operations at 113600000.0 in Q1 2026, 175400000.0 in Q4 2025, and 51700000.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 411.00 Mn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 655.00 Mn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 800.69 Mn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 313.60 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 381.80 Mn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 136.40 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 277.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | Perrigo | 1.91 Bn | 1.51 Bn | 313.90 Mn | 82.60 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 27, 2026 | 82.60 Mn |
| Jun 27, 2026 | 82.60 Mn |
| Mar 28, 2026 | -113.60 Mn |
| Mar 28, 2026 | -113.60 Mn |
| Dec 31, 2025 | 175.40 Mn |
| Dec 31, 2025 | 175.40 Mn |
| Sep 27, 2025 | 51.70 Mn |
| Sep 27, 2025 | 51.70 Mn |
| Jun 28, 2025 | 75.90 Mn |
| Jun 28, 2025 | 75.90 Mn |
| Mar 29, 2025 | -64.50 Mn |
| Mar 29, 2025 | -64.50 Mn |
| Dec 31, 2024 | 312.60 Mn |
| Dec 31, 2024 | 312.60 Mn |
| Sep 28, 2024 | 42.20 Mn |
| Sep 28, 2024 | 42.20 Mn |
| Jun 29, 2024 | 9.50 Mn |
| Jun 29, 2024 | 9.50 Mn |
| Mar 30, 2024 | -1.40 Mn |
| Mar 30, 2024 | -1.40 Mn |